ACTIVE SUBSTANCE / INN

ERYTHROMYCIN ETHYLSUCCINATE

Brand name(s): PEDIAZOLE, PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE, PEDIAMYCIN, E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYPED, E.E.S.
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA062759
ANDA062304
ACTIVE SUBSTANCE
Erythromycin Ethylsuccinate
REGULATORS
FDA
SPONSORS / MAH
AZURITY, AMNEAL PHARMS, PHARMAFAIR
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ERYTHROMYCIN ETHYLSUCCINATEANDA211204AMNEAL PHARMSPrescription
E.E.S. 400ANDA061905CARNEGIEDiscontinued
E.E.S. 400ANDA061905CARNEGIEPrescription
PEDIAMYCIN 400ANDA062304ARBOR PHARMS LLCDiscontinued
PEDIAMYCINANDA062304ARBOR PHARMS LLCDiscontinued
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYLANDA062759BARRDiscontinued
E.E.S.NDA050297AZURITYDiscontinued
ERYPEDNDA050297AZURITYDiscontinued
ERYTHROMYCIN ETHYLSUCCINATEANDA062558PHARMAFAIRDiscontinued
PEDIAZOLENDA050529ROSS LABSDiscontinued

FULL INTELLIGENCE ON ERYTHROMYCIN ETHYLSUCCINATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →